This study is designed to determine whether an oral perioperative medication (alvimopan--a selective mu antagonist) improves bowel recovery over placebo after surgery for ovarian cancer.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
146
Mayo Clinic
Rochester, Minnesota, United States
Postoperative Length of Hospital Stay
Length of stay = date/time of hospital dismissal - date/time of end of surgery
Time frame: Patients will be followed for the duration of their hospital stay, an expected average of 5 days
Postoperative Ileus Incidence
Ileus was defined as MD-diagnosed, return to nothing by mouth (NPO) status, or insertion of nasogastric tube for ileus.
Time frame: Patients will be followed for 30 days postop
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.